| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 2 | |
| #2 | United States | 2 | |
| #3 | WIPO (World Intellectual Property Organization) | 2 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | Hong Kong | 1 | |
| #7 | Japan | 1 | |
| #8 | Mexico | 1 | |
| #9 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Microorganisms | |
| #5 | Enzymes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Littman Bruce H | 9 |
| #2 | Thompson John F | 8 |
| #3 | Marcoux Frank W | 8 |
| #4 | Frank W Marcoux | 2 |
| #5 | John F Thompson | 2 |
| #6 | Bruce H Littman | 2 |
| #7 | Littman Bruce H H | 1 |
| #8 | Marcoux Frank W W | 1 |
| #9 | Thompson John F F | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2017189826A1 | Use of cell-permeable peptides and non-peptide carriers conjugated with nemo binding domain cargo sequence for the treatment of dry eye disease and uveitis | |
| US2016136293A1 | Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides |